Skip to content

Impax Laboratories, LLC

CIK 0001003642

← back to feed
Revenue (TTM)
$735.23M
−11.4% YoY Q1 May 2018
Net Income (TTM)
−$195.46M
−509.8% YoY Q1 May 2018
EPS Diluted (TTM)
−$4.15
−505.8% YoY Q1 May 2018
Gross Margin
22.0%
Q1 May 2018
Operating Margin
-30.0%
Q1 May 2018
Net Margin
-26.6%
Q1 May 2018
Free Cash Flow (TTM)
$29.15M
Q1 May 2018
Cash
$104.19M
Q1 May 2018
Total Debt
$789.08M
Q1 May 2018
Shares Outstanding
73.76M sh
Q1 May 2018

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings